Literature DB >> 21652170

Real-world estimated effective radiation doses from commonly used cardiac testing and procedural modalities.

Andrew Scott-Moncrieff1, Jiao Yang, Daniel Levine, Carolyn Taylor, David Tso, Mark Johnson, Brett Heilbron, Jonathan Leipsic.   

Abstract

BACKGROUND: The volume of cardiac diagnostic tests that are performed has increased significantly in recent years. The benefits of these tests should be weighed against the risks, including exposure to ionizing radiation. We sought to determine the effective radiation doses associated with common cardiac imaging studies performed at a provincial referral heart centre in Vancouver, Canada, between January 1, 2009 and December 31, 2009.
METHODS: Effective radiation dose was calculated for all patients who underwent clinically indicated cardiac computed tomography angiography (CCTA), myocardial perfusion imaging (MPI), and diagnostic catheter coronary angiography (CCA) in 2009. The dose from CCTA and CCA studies was estimated from dose-length product and dose area product values, respectively. A conversion factor of 0.014 mSv/(mGy × cm) was used for CCTA and MPI CT attenuation correction. The conversion factor for CCA was 0.22 mSv/(Gy × cm(2)). The effective radiation dose for MPI was calculated using: E = (E/A) × A(o) where E = effective dose, E/A is an effective dose coefficient, and A(o) is the radiotracer activity.
RESULTS: There were 673 CCTA studies and 2306 MPI studies performed with average effective doses of 3.7 mSv and 16.8 mSv, respectively. There were 2628 diagnostic CCA studies performed with an average effective dose of 11.4 mSv.
CONCLUSIONS: There was a wide range of effective radiation doses between imaging modalities. These tests provide different clinical information and the appropriate test must be chosen with radiation dose in mind. The implementation of dose reduction strategies has the potential to significantly reduce these doses.
Copyright © 2011 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21652170     DOI: 10.1016/j.cjca.2011.01.011

Source DB:  PubMed          Journal:  Can J Cardiol        ISSN: 0828-282X            Impact factor:   5.223


  5 in total

1.  Quantification of radiation dose reduction by reducing z-axis coverage in 320-detector coronary CT angiography.

Authors:  David J Murphy; Abhishek Keraliya; Nathan Himes; Ayaz Aghayev; Ron Blankstein; Michael L Steigner
Journal:  Br J Radiol       Date:  2017-06-14       Impact factor: 3.039

Review 2.  Clinical review: Screening for coronary artery disease in type 2 diabetes.

Authors:  Charles T Upchurch; Eugene J Barrett
Journal:  J Clin Endocrinol Metab       Date:  2012-03-14       Impact factor: 5.958

3.  The Incremental Diagnostic Performance of Coronary Computed Tomography Angiography Added to Myocardial Perfusion Imaging in Patients with Intermediate-to-High Cardiovascular Risk.

Authors:  Pei-Ying Hsu; Wen-Jeng Lee; Mei-Fang Cheng; Ruoh-Fang Yen; Kai-Yuan Tzen; Yen-Wen Wu
Journal:  Acta Cardiol Sin       Date:  2016-03       Impact factor: 2.672

Review 4.  Noninvasive diagnosis of chemotherapy related cardiotoxicity.

Authors:  Hamilton S Gillespie; Christopher J McGann; Brent D Wilson
Journal:  Curr Cardiol Rev       Date:  2011-11

5.  Double-contrast, single-phase computed tomography angiography for ruling out left atrial appendage thrombus prior to atrial fibrillation ablation.

Authors:  Cas Teunissen; Jesse Habets; Birgitta K Velthuis; Maarten J Cramer; Peter Loh
Journal:  Int J Cardiovasc Imaging       Date:  2016-09-06       Impact factor: 2.357

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.